ALS Limited provides analytical testing services in Australia, Canada, the United States, and internationally.
Average dividend payer with mediocre balance sheet.
Share Price & News
How has ALS's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ALQ's share price has been volatile over the past 3 months.
7 Day Return
AU Professional Services
1 Year Return
AU Professional Services
Return vs Industry: ALQ exceeded the Australian Professional Services industry which returned -7.3% over the past year.
Return vs Market: ALQ exceeded the Australian Market which returned -13.6% over the past year.
Price Volatility Vs. Market
How volatile is ALS's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StFactors Income Investors Should Consider Before Adding ALS Limited (ASX:ALQ) To Their Portfolio
3 weeks ago | Simply Wall StCould The ALS Limited (ASX:ALQ) Ownership Structure Tell Us Something Useful?
1 month ago | Simply Wall StHow Much is ALS Limited's (ASX:ALQ) CEO Getting Paid?
Is ALS undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ALQ (A$7.05) is trading above our estimate of fair value (A$4.89)
Significantly Below Fair Value: ALQ is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ALQ is poor value based on its PE Ratio (20.5x) compared to the Professional Services industry average (13.9x).
PE vs Market: ALQ is poor value based on its PE Ratio (20.5x) compared to the Australian market (14.8x).
Price to Earnings Growth Ratio
PEG Ratio: ALQ's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: ALQ is overvalued based on its PB Ratio (3x) compared to the AU Professional Services industry average (1.9x).
How is ALS forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALQ's earnings are forecast to decline over the next 3 years (-1.1% per year).
Earnings vs Market: ALQ's earnings are forecast to decline over the next 3 years (-1.1% per year).
High Growth Earnings: ALQ's earnings are forecast to decline over the next 3 years.
Revenue vs Market: ALQ's revenue (0.8% per year) is forecast to grow slower than the Australian market (4.3% per year).
High Growth Revenue: ALQ's revenue (0.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALQ's Return on Equity is forecast to be low in 3 years time (14.3%).
How has ALS performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ALQ has high quality earnings.
Growing Profit Margin: ALQ's current net profit margins (9.5%) are lower than last year (9.6%).
Past Earnings Growth Analysis
Earnings Trend: ALQ's earnings have grown significantly by 49% per year over the past 5 years.
Accelerating Growth: ALQ's earnings growth over the past year (11.3%) is below its 5-year average (49% per year).
Earnings vs Industry: ALQ earnings growth over the past year (11.3%) underperformed the Professional Services industry 12%.
Return on Equity
High ROE: ALQ's Return on Equity (14.7%) is considered low.
How is ALS's financial position?
Financial Position Analysis
Short Term Liabilities: ALQ's short term assets (A$670.0M) exceed its short term liabilities (A$344.9M).
Long Term Liabilities: ALQ's short term assets (A$670.0M) do not cover its long term liabilities (A$1.1B).
Debt to Equity History and Analysis
Debt Level: ALQ's debt to equity ratio (73.8%) is considered high.
Reducing Debt: ALQ's debt to equity ratio has increased from 62.6% to 73.8% over the past 5 years.
Debt Coverage: ALQ's debt is well covered by operating cash flow (26.1%).
Interest Coverage: ALQ's interest payments on its debt are well covered by EBIT (8.3x coverage).
What is ALS's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ALQ's dividend (3.26%) is higher than the bottom 25% of dividend payers in the Australian market (2.67%).
High Dividend: ALQ's dividend (3.26%) is low compared to the top 25% of dividend payers in the Australian market (6.98%).
Stability and Growth of Payments
Stable Dividend: ALQ's dividend payments have been volatile in the past 10 years.
Growing Dividend: ALQ's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (66.7%), ALQ's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ALQ's dividends in 3 years are forecast to be covered by earnings (56.2% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Raj Naran (57yo)
Mr. Raj Naran, BSc (Chemistry), BA (Mathematics), has been Managing Director, Chief Executive Officer and Director at ALS Limited since July 20, 2017. Mr. Naran served as the Group General Manager of Life ...
CEO Compensation Analysis
Compensation vs Market: Raj's total compensation ($USD1.92M) is above average for companies of similar size in the Australian market ($USD1.47M).
Compensation vs Earnings: Raj's compensation has been consistent with company performance over the past year.
|MD, CEO & Director||2.83yrs||AU$2.93m||0.031% A$1.1m|
|Chief Financial Officer||1.67yrs||AU$1.08m||no data|
|General Manager of Geochemistry||8.08yrs||AU$1.14m||0.0032% A$107.1k|
|General Manager of Industrial||no data||AU$775.10k||0.0074% A$251.3k|
|General Manager of Life Sciences APAC||3.08yrs||AU$748.62k||0.0038% A$128.2k|
|General Manager of Life Sciences Europe||3.08yrs||AU$798.35k||0.0063% A$215.3k|
|General Counsel & Company Secretary||2.42yrs||no data||no data|
|Global Head of Human Resources||12.33yrs||no data||no data|
|Chief Risk Officer||no data||no data||no data|
|Group Financial Controller||no data||no data||no data|
Experienced Management: ALQ's management team is considered experienced (3.1 years average tenure).
|MD, CEO & Director||2.83yrs||AU$2.93m||0.031% A$1.1m|
|Independent Non-Executive Director||8.25yrs||AU$182.75k||0.011% A$380.9k|
|Independent Chairman||3.83yrs||AU$343.25k||0.012% A$424.1k|
|Independent Non-Executive Director||5.25yrs||AU$189.85k||0.019% A$634.6k|
|Independent Non-Executive Director||3.83yrs||AU$184.46k||0.0056% A$191.5k|
|Independent Non-Executive Director||0.50yr||no data||no data|
|Independent Non-Executive Director||8.67yrs||AU$196.35k||0.015% A$515.2k|
|Independent Non-Executive Director||1.33yrs||AU$37.05k||no data|
Experienced Board: ALQ's board of directors are considered experienced (3.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
ALS Limited's company bio, employee growth, exchange listings and data sources
- Name: ALS Limited
- Ticker: ALQ
- Exchange: ASX
- Founded: 1863
- Industry: Research and Consulting Services
- Sector: Commercial Services
- Market Cap: AU$3.401b
- Shares outstanding: 482.39m
- Website: https://www.alsglobal.com
Number of Employees
- ALS Limited
- 32 Shand Street
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ALQ||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Jan 1992|
|CPBL.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Jan 1992|
|CP4||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jan 1992|
|ALQ||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Jan 1992|
ALS Limited provides analytical testing services in Australia, Canada, the United States, and internationally. The company’s Commodities segment provides testing services for the mining and mineral exploration companies in geochemistry, metallurgy, inspection, and coal quality areas. This segment’s services cover the resource life-cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. It also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services; and field and laboratory services, such as bore core, testing, consulting, quality management, and superintendent services to the coal industry. Its Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets. It provides analytical testing data to assist consulting and engineering firms, industries, and governments. The company’s Industrial segment offers diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. This segment serves asset owners, operators, constructors, and equipment manufacturers in the power, petrochemical, mining, minerals processing, water, infrastructure, and transportation industries. The company was formerly known as Campbell Brothers Limited and changed its name to ALS Limited in August 2012. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/05/27 12:12|
|End of Day Share Price||2020/05/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.